Regional Differences in Hepatocellular Carcinoma and its Surgical Treatment

Regional Differences in Hepatocellular Carcinoma and its Surgical Treatment

Hepatocellular carcinoma (HCC) is probably the commonest malignant tumour in males in the world and is responsible for approximately 1,000,000 deaths annually1’2. In China, most of Southeast Asia and Sub-Saharan Africa it occurs at a rate of 20 to 150 per 100,000 a year, whilst in the USA and Europe the rate ranges from 1 to 5 per 100,000 a year3’4. In all countries it shows a marked male prepo...

Loco-regional treatment of hepatocellular carcinoma.

Loco-regional treatments play a key role in the management of hepatocellular carcinoma (HCC). Image-guided tumor ablation is recommended in patients with early-stage HCC when surgical options are precluded. Radiofrequency ablation has shown superior anticancer effects and greater survival benefit with respect to the seminal percutaneous technique, ethanol injection, in meta-analyses of randomiz...

Hepatocellular Carcinoma in Sheep

Surgical Treatment Strategies and Prognosis of Hepatocellular Carcinoma

Preclinical studies of 166Ho-chitosan for treatment of hepatocellular carcinoma

Introduction: Recently, due to the special characteristics of 166Ho and chitosan, 166Ho-chitosan complex was developed for treatment of tumors such as hepatocellular carcinoma. This complex has been lately prepared with high radiochemical purity in our lab. The preclinical studies of the complex however should be performed to evaluate the tracer concentration in target and...